GCM
DXCM icon

Genus Capital Management’s DexCom DXCM Stock Holding History

Genus Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,570
Closed -$4.24M – 250
2024
Q1 		$4.66M Buy
+33,570
New +$4.22M 0.6% 54
2023
Q4 		– Sell
-12,400
Closed -$1.27M – 243
2023
Q3 		$1.16M Buy
+12,400
New +$1.4M 0.18% 122

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Genus Capital Management's DXCM Position: Q2 2024 in Review

Genus Capital Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 33,570 shares — an estimated $4.24M sold.

Genus Capital Management first reported a position in DXCM in Q3 2023 and held it in 2 quarters. The position peaked at $4.66M in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Genus Capital Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Genus Capital Management sold 33,570 DexCom shares in Q2 2024, an estimated $4.24M.
  • Genus Capital Management first reported a position in DexCom in Q3 2023 and held it in 2 quarters.
  • Genus Capital Management's DexCom position peaked at $4.66M in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Genus Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.